Welcome
Support Centre
06 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
DClinPsy: Maladaptive cognitive processes during exposure in people with OCD (checking subtype)
ISRCTN ISRCTN60061491
ClinicalTrials.gov identifier
Public title DClinPsy: Maladaptive cognitive processes during exposure in people with OCD (checking subtype)
Scientific title
Acronym N/A
Serial number at source N0266190334
Study hypothesis The research aims to identify covert cognitive strategies that are used by individuals with Obsessive Compulsive Disorder (checking subtype) (OCD) when they are exposed to fear provoking stimuli. The principle objective is to increase our understanding of OCD and to refine and improve cognitive treatments for OCD.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Mental and Behavioural Disorders: Obsessive compulsive disorder (OCD)
Participants - inclusion criteria 1. Referred to Leeds Clinical Psychology services
2. Aged between 16-65
3. Meets diagnostic criteria for OCD
4. OCD is the main presenting problem
5. Checking symptoms are the primary presenting symptom of the disorder
Participants - exclusion criteria 1. The assessment reveals a suicide or self-harm risk
2. Alcohol or drug dependence
3. Learning disability
4. Psychosis
Anticipated start date 01/09/2006
Anticipated end date 30/06/2007
Status of trial Completed
Patient information material
Target number of participants 15 as of February 2007
Interventions HYPOTHESIS 1
Asking a participant with OCD (checking subtype) to search for a perfect memory will lead to an increase in anxiety, urge to check and belief that the item was not properly checked compared to a condition in which a participant is asked to abandon a memory search.

HYPOTHESIS 2
Asking a participant with OCD (checking subtype) to consider a series of Socratic questions about the likelihood that an item was not checked properly will lead to an increase in anxiety, urge to check and belief that the item was not checked properly will lead to an increase in anxiety, urge to check and belief that the item was not checked properly compared to a condition in which the participant uses detached mindfulness.

The study will use two ABC single-case series experimental designs. Conditions B and C will be counterbalanced: Half of the participants will be randomly assigned to receive condition B before C; the other participants will receive condition C and then B. This is to ensure that the effects of the experimental manipulations are not due simply to the order in which they were given.

STAGE 1: BASELINE (CONDITION A)
In the baseline experiment participants will be exposed to their fear provoking stimuli, which may differ between participants. For example, one participant may need to switch off an electrical appliance and walk away without checking whilst another may need to lock a car door. The participant will then spend five minutes doing what they normally do when they have just che4cked something (with the exception of going back to check) and will fill in their visual analogue scales.

STAGE 2: EXPERIMENT 1 (CONDITION B)
Participants will be given a rationale about the use of memory searching as a technique people sometime use to prevent them from checking. Once the Principal Investigator is confident that the participant understands how to do a memory search, the participant will repeat their exposure to the fear producing stimuli and then return to the research room to engage in a five minute memory search whilst completing the visual analogue scale.

STAGE 3: EXPERIMENT 1 (CONDITION C)
Participants will be given a rationale which suggests why memory searching may not be useful. The participant will then be asked to think of ways to abandon doing a memory search. Once the Principal Investigator is confident that the participant is able to abandon the memory search, the participant will repeat their exposure to the feared stimuli and then return to the research room to engage in five minutes of deliberately not searching their memory whilst completing the visual analogue scales.

EXPERIMENT 2
Experiment 2 will take place approximately one week after the first experimental session. The design of the experiment will be exactly the same as experiment 1 except that it will test hypothesis 2. The rationales will therefore be on the use of Socratic questioning and the use of detached mindfulness.
Primary outcome measure(s) Visual analogue scales used standardly in CBT
Secondary outcome measure(s) 1. MINI International Neuropsychiatric Interview
2. Yale-Brown Obsessive Compulsive Scale
3. Padua Inventory
4. Maudsley Obsessive-Compulsive Inventory
5. Beck Depression Inventory - 1st and 2nd editions
Sources of funding South West Yorkshire Mental Health NHS Trust
NHS R&D Support Funding
Trial website
Publications
Contact name Miss  Stacey  Danks
  Address Academic Unit of Psychiatry & Behavioural Sciences
University of Leeds
15 Hyde Terrace
  City/town Leeds
  Zip/Postcode LS2 9LT
  Country United Kingdom
  Tel +44 0114 268 5525
  Fax +44
  Email
Sponsor Record Provided by the NHSTCT Register - 2007 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 28/09/2007
Last edited 07/07/2009
Date ISRCTN assigned 28/09/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central